Global Inherited Cancer Genome Testing Market Research Report 2024(Status and Outlook)
Report Overview
This report provides a deep insight into the global Inherited Cancer Genome Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Inherited Cancer Genome Testing Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Inherited Cancer Genome Testing market in any manner.
Global Inherited Cancer Genome Testing Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
23andMe
Agilent Technologies
Bio-Rad Laboratories
Centogene
Color Genomics
Gene By Gene
Illumina
LabCorp
Myriad Genetics
Positive Bioscience
Quest Diagnostics
Thermo Fisher Scientific
Market Segmentation (by Type)
Breast Cancer
Lung Cancer
Blood Cancer
Liver Cancer
Stomach Cancer
Others
Market Segmentation (by Application)
General Hospitals
Specialty Clinics
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Inherited Cancer Genome Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
This report provides a deep insight into the global Inherited Cancer Genome Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Inherited Cancer Genome Testing Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Inherited Cancer Genome Testing market in any manner.
Global Inherited Cancer Genome Testing Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
23andMe
Agilent Technologies
Bio-Rad Laboratories
Centogene
Color Genomics
Gene By Gene
Illumina
LabCorp
Myriad Genetics
Positive Bioscience
Quest Diagnostics
Thermo Fisher Scientific
Market Segmentation (by Type)
Breast Cancer
Lung Cancer
Blood Cancer
Liver Cancer
Stomach Cancer
Others
Market Segmentation (by Application)
General Hospitals
Specialty Clinics
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Inherited Cancer Genome Testing Market
- Overview of the regional outlook of the Inherited Cancer Genome Testing Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Inherited Cancer Genome Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Inherited Cancer Genome Testing
1.2 Key Market Segments
1.2.1 Inherited Cancer Genome Testing Segment by Type
1.2.2 Inherited Cancer Genome Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INHERITED CANCER GENOME TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Inherited Cancer Genome Testing Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Inherited Cancer Genome Testing Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INHERITED CANCER GENOME TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Global Inherited Cancer Genome Testing Sales by Manufacturers (2019-2024)
3.2 Global Inherited Cancer Genome Testing Revenue Market Share by Manufacturers (2019-2024)
3.3 Inherited Cancer Genome Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Inherited Cancer Genome Testing Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Inherited Cancer Genome Testing Sales Sites, Area Served, Product Type
3.6 Inherited Cancer Genome Testing Market Competitive Situation and Trends
3.6.1 Inherited Cancer Genome Testing Market Concentration Rate
3.6.2 Global 5 and 10 Largest Inherited Cancer Genome Testing Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 INHERITED CANCER GENOME TESTING INDUSTRY CHAIN ANALYSIS
4.1 Inherited Cancer Genome Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INHERITED CANCER GENOME TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 INHERITED CANCER GENOME TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Inherited Cancer Genome Testing Sales Market Share by Type (2019-2024)
6.3 Global Inherited Cancer Genome Testing Market Size Market Share by Type (2019-2024)
6.4 Global Inherited Cancer Genome Testing Price by Type (2019-2024)
7 INHERITED CANCER GENOME TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Inherited Cancer Genome Testing Market Sales by Application (2019-2024)
7.3 Global Inherited Cancer Genome Testing Market Size (M USD) by Application (2019-2024)
7.4 Global Inherited Cancer Genome Testing Sales Growth Rate by Application (2019-2024)
8 INHERITED CANCER GENOME TESTING MARKET SEGMENTATION BY REGION
8.1 Global Inherited Cancer Genome Testing Sales by Region
8.1.1 Global Inherited Cancer Genome Testing Sales by Region
8.1.2 Global Inherited Cancer Genome Testing Sales Market Share by Region
8.2 North America
8.2.1 North America Inherited Cancer Genome Testing Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Inherited Cancer Genome Testing Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Inherited Cancer Genome Testing Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Inherited Cancer Genome Testing Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Inherited Cancer Genome Testing Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 23andMe
9.1.1 23andMe Inherited Cancer Genome Testing Basic Information
9.1.2 23andMe Inherited Cancer Genome Testing Product Overview
9.1.3 23andMe Inherited Cancer Genome Testing Product Market Performance
9.1.4 23andMe Business Overview
9.1.5 23andMe Inherited Cancer Genome Testing SWOT Analysis
9.1.6 23andMe Recent Developments
9.2 Agilent Technologies
9.2.1 Agilent Technologies Inherited Cancer Genome Testing Basic Information
9.2.2 Agilent Technologies Inherited Cancer Genome Testing Product Overview
9.2.3 Agilent Technologies Inherited Cancer Genome Testing Product Market Performance
9.2.4 Agilent Technologies Business Overview
9.2.5 Agilent Technologies Inherited Cancer Genome Testing SWOT Analysis
9.2.6 Agilent Technologies Recent Developments
9.3 Bio-Rad Laboratories
9.3.1 Bio-Rad Laboratories Inherited Cancer Genome Testing Basic Information
9.3.2 Bio-Rad Laboratories Inherited Cancer Genome Testing Product Overview
9.3.3 Bio-Rad Laboratories Inherited Cancer Genome Testing Product Market Performance
9.3.4 Bio-Rad Laboratories Inherited Cancer Genome Testing SWOT Analysis
9.3.5 Bio-Rad Laboratories Business Overview
9.3.6 Bio-Rad Laboratories Recent Developments
9.4 Centogene
9.4.1 Centogene Inherited Cancer Genome Testing Basic Information
9.4.2 Centogene Inherited Cancer Genome Testing Product Overview
9.4.3 Centogene Inherited Cancer Genome Testing Product Market Performance
9.4.4 Centogene Business Overview
9.4.5 Centogene Recent Developments
9.5 Color Genomics
9.5.1 Color Genomics Inherited Cancer Genome Testing Basic Information
9.5.2 Color Genomics Inherited Cancer Genome Testing Product Overview
9.5.3 Color Genomics Inherited Cancer Genome Testing Product Market Performance
9.5.4 Color Genomics Business Overview
9.5.5 Color Genomics Recent Developments
9.6 Gene By Gene
9.6.1 Gene By Gene Inherited Cancer Genome Testing Basic Information
9.6.2 Gene By Gene Inherited Cancer Genome Testing Product Overview
9.6.3 Gene By Gene Inherited Cancer Genome Testing Product Market Performance
9.6.4 Gene By Gene Business Overview
9.6.5 Gene By Gene Recent Developments
9.7 Illumina
9.7.1 Illumina Inherited Cancer Genome Testing Basic Information
9.7.2 Illumina Inherited Cancer Genome Testing Product Overview
9.7.3 Illumina Inherited Cancer Genome Testing Product Market Performance
9.7.4 Illumina Business Overview
9.7.5 Illumina Recent Developments
9.8 LabCorp
9.8.1 LabCorp Inherited Cancer Genome Testing Basic Information
9.8.2 LabCorp Inherited Cancer Genome Testing Product Overview
9.8.3 LabCorp Inherited Cancer Genome Testing Product Market Performance
9.8.4 LabCorp Business Overview
9.8.5 LabCorp Recent Developments
9.9 Myriad Genetics
9.9.1 Myriad Genetics Inherited Cancer Genome Testing Basic Information
9.9.2 Myriad Genetics Inherited Cancer Genome Testing Product Overview
9.9.3 Myriad Genetics Inherited Cancer Genome Testing Product Market Performance
9.9.4 Myriad Genetics Business Overview
9.9.5 Myriad Genetics Recent Developments
9.10 Positive Bioscience
9.10.1 Positive Bioscience Inherited Cancer Genome Testing Basic Information
9.10.2 Positive Bioscience Inherited Cancer Genome Testing Product Overview
9.10.3 Positive Bioscience Inherited Cancer Genome Testing Product Market Performance
9.10.4 Positive Bioscience Business Overview
9.10.5 Positive Bioscience Recent Developments
9.11 Quest Diagnostics
9.11.1 Quest Diagnostics Inherited Cancer Genome Testing Basic Information
9.11.2 Quest Diagnostics Inherited Cancer Genome Testing Product Overview
9.11.3 Quest Diagnostics Inherited Cancer Genome Testing Product Market Performance
9.11.4 Quest Diagnostics Business Overview
9.11.5 Quest Diagnostics Recent Developments
9.12 Thermo Fisher Scientific
9.12.1 Thermo Fisher Scientific Inherited Cancer Genome Testing Basic Information
9.12.2 Thermo Fisher Scientific Inherited Cancer Genome Testing Product Overview
9.12.3 Thermo Fisher Scientific Inherited Cancer Genome Testing Product Market Performance
9.12.4 Thermo Fisher Scientific Business Overview
9.12.5 Thermo Fisher Scientific Recent Developments
10 INHERITED CANCER GENOME TESTING MARKET FORECAST BY REGION
10.1 Global Inherited Cancer Genome Testing Market Size Forecast
10.2 Global Inherited Cancer Genome Testing Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Inherited Cancer Genome Testing Market Size Forecast by Country
10.2.3 Asia Pacific Inherited Cancer Genome Testing Market Size Forecast by Region
10.2.4 South America Inherited Cancer Genome Testing Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Inherited Cancer Genome Testing by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Inherited Cancer Genome Testing Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Inherited Cancer Genome Testing by Type (2025-2030)
11.1.2 Global Inherited Cancer Genome Testing Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Inherited Cancer Genome Testing by Type (2025-2030)
11.2 Global Inherited Cancer Genome Testing Market Forecast by Application (2025-2030)
11.2.1 Global Inherited Cancer Genome Testing Sales (K Units) Forecast by Application
11.2.2 Global Inherited Cancer Genome Testing Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Inherited Cancer Genome Testing
1.2 Key Market Segments
1.2.1 Inherited Cancer Genome Testing Segment by Type
1.2.2 Inherited Cancer Genome Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INHERITED CANCER GENOME TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Inherited Cancer Genome Testing Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Inherited Cancer Genome Testing Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INHERITED CANCER GENOME TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Global Inherited Cancer Genome Testing Sales by Manufacturers (2019-2024)
3.2 Global Inherited Cancer Genome Testing Revenue Market Share by Manufacturers (2019-2024)
3.3 Inherited Cancer Genome Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Inherited Cancer Genome Testing Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Inherited Cancer Genome Testing Sales Sites, Area Served, Product Type
3.6 Inherited Cancer Genome Testing Market Competitive Situation and Trends
3.6.1 Inherited Cancer Genome Testing Market Concentration Rate
3.6.2 Global 5 and 10 Largest Inherited Cancer Genome Testing Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 INHERITED CANCER GENOME TESTING INDUSTRY CHAIN ANALYSIS
4.1 Inherited Cancer Genome Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INHERITED CANCER GENOME TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 INHERITED CANCER GENOME TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Inherited Cancer Genome Testing Sales Market Share by Type (2019-2024)
6.3 Global Inherited Cancer Genome Testing Market Size Market Share by Type (2019-2024)
6.4 Global Inherited Cancer Genome Testing Price by Type (2019-2024)
7 INHERITED CANCER GENOME TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Inherited Cancer Genome Testing Market Sales by Application (2019-2024)
7.3 Global Inherited Cancer Genome Testing Market Size (M USD) by Application (2019-2024)
7.4 Global Inherited Cancer Genome Testing Sales Growth Rate by Application (2019-2024)
8 INHERITED CANCER GENOME TESTING MARKET SEGMENTATION BY REGION
8.1 Global Inherited Cancer Genome Testing Sales by Region
8.1.1 Global Inherited Cancer Genome Testing Sales by Region
8.1.2 Global Inherited Cancer Genome Testing Sales Market Share by Region
8.2 North America
8.2.1 North America Inherited Cancer Genome Testing Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Inherited Cancer Genome Testing Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Inherited Cancer Genome Testing Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Inherited Cancer Genome Testing Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Inherited Cancer Genome Testing Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 23andMe
9.1.1 23andMe Inherited Cancer Genome Testing Basic Information
9.1.2 23andMe Inherited Cancer Genome Testing Product Overview
9.1.3 23andMe Inherited Cancer Genome Testing Product Market Performance
9.1.4 23andMe Business Overview
9.1.5 23andMe Inherited Cancer Genome Testing SWOT Analysis
9.1.6 23andMe Recent Developments
9.2 Agilent Technologies
9.2.1 Agilent Technologies Inherited Cancer Genome Testing Basic Information
9.2.2 Agilent Technologies Inherited Cancer Genome Testing Product Overview
9.2.3 Agilent Technologies Inherited Cancer Genome Testing Product Market Performance
9.2.4 Agilent Technologies Business Overview
9.2.5 Agilent Technologies Inherited Cancer Genome Testing SWOT Analysis
9.2.6 Agilent Technologies Recent Developments
9.3 Bio-Rad Laboratories
9.3.1 Bio-Rad Laboratories Inherited Cancer Genome Testing Basic Information
9.3.2 Bio-Rad Laboratories Inherited Cancer Genome Testing Product Overview
9.3.3 Bio-Rad Laboratories Inherited Cancer Genome Testing Product Market Performance
9.3.4 Bio-Rad Laboratories Inherited Cancer Genome Testing SWOT Analysis
9.3.5 Bio-Rad Laboratories Business Overview
9.3.6 Bio-Rad Laboratories Recent Developments
9.4 Centogene
9.4.1 Centogene Inherited Cancer Genome Testing Basic Information
9.4.2 Centogene Inherited Cancer Genome Testing Product Overview
9.4.3 Centogene Inherited Cancer Genome Testing Product Market Performance
9.4.4 Centogene Business Overview
9.4.5 Centogene Recent Developments
9.5 Color Genomics
9.5.1 Color Genomics Inherited Cancer Genome Testing Basic Information
9.5.2 Color Genomics Inherited Cancer Genome Testing Product Overview
9.5.3 Color Genomics Inherited Cancer Genome Testing Product Market Performance
9.5.4 Color Genomics Business Overview
9.5.5 Color Genomics Recent Developments
9.6 Gene By Gene
9.6.1 Gene By Gene Inherited Cancer Genome Testing Basic Information
9.6.2 Gene By Gene Inherited Cancer Genome Testing Product Overview
9.6.3 Gene By Gene Inherited Cancer Genome Testing Product Market Performance
9.6.4 Gene By Gene Business Overview
9.6.5 Gene By Gene Recent Developments
9.7 Illumina
9.7.1 Illumina Inherited Cancer Genome Testing Basic Information
9.7.2 Illumina Inherited Cancer Genome Testing Product Overview
9.7.3 Illumina Inherited Cancer Genome Testing Product Market Performance
9.7.4 Illumina Business Overview
9.7.5 Illumina Recent Developments
9.8 LabCorp
9.8.1 LabCorp Inherited Cancer Genome Testing Basic Information
9.8.2 LabCorp Inherited Cancer Genome Testing Product Overview
9.8.3 LabCorp Inherited Cancer Genome Testing Product Market Performance
9.8.4 LabCorp Business Overview
9.8.5 LabCorp Recent Developments
9.9 Myriad Genetics
9.9.1 Myriad Genetics Inherited Cancer Genome Testing Basic Information
9.9.2 Myriad Genetics Inherited Cancer Genome Testing Product Overview
9.9.3 Myriad Genetics Inherited Cancer Genome Testing Product Market Performance
9.9.4 Myriad Genetics Business Overview
9.9.5 Myriad Genetics Recent Developments
9.10 Positive Bioscience
9.10.1 Positive Bioscience Inherited Cancer Genome Testing Basic Information
9.10.2 Positive Bioscience Inherited Cancer Genome Testing Product Overview
9.10.3 Positive Bioscience Inherited Cancer Genome Testing Product Market Performance
9.10.4 Positive Bioscience Business Overview
9.10.5 Positive Bioscience Recent Developments
9.11 Quest Diagnostics
9.11.1 Quest Diagnostics Inherited Cancer Genome Testing Basic Information
9.11.2 Quest Diagnostics Inherited Cancer Genome Testing Product Overview
9.11.3 Quest Diagnostics Inherited Cancer Genome Testing Product Market Performance
9.11.4 Quest Diagnostics Business Overview
9.11.5 Quest Diagnostics Recent Developments
9.12 Thermo Fisher Scientific
9.12.1 Thermo Fisher Scientific Inherited Cancer Genome Testing Basic Information
9.12.2 Thermo Fisher Scientific Inherited Cancer Genome Testing Product Overview
9.12.3 Thermo Fisher Scientific Inherited Cancer Genome Testing Product Market Performance
9.12.4 Thermo Fisher Scientific Business Overview
9.12.5 Thermo Fisher Scientific Recent Developments
10 INHERITED CANCER GENOME TESTING MARKET FORECAST BY REGION
10.1 Global Inherited Cancer Genome Testing Market Size Forecast
10.2 Global Inherited Cancer Genome Testing Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Inherited Cancer Genome Testing Market Size Forecast by Country
10.2.3 Asia Pacific Inherited Cancer Genome Testing Market Size Forecast by Region
10.2.4 South America Inherited Cancer Genome Testing Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Inherited Cancer Genome Testing by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Inherited Cancer Genome Testing Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Inherited Cancer Genome Testing by Type (2025-2030)
11.1.2 Global Inherited Cancer Genome Testing Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Inherited Cancer Genome Testing by Type (2025-2030)
11.2 Global Inherited Cancer Genome Testing Market Forecast by Application (2025-2030)
11.2.1 Global Inherited Cancer Genome Testing Sales (K Units) Forecast by Application
11.2.2 Global Inherited Cancer Genome Testing Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Inherited Cancer Genome Testing Market Size Comparison by Region (M USD)
Table 5. Global Inherited Cancer Genome Testing Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Inherited Cancer Genome Testing Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Inherited Cancer Genome Testing Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Inherited Cancer Genome Testing Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inherited Cancer Genome Testing as of 2022)
Table 10. Global Market Inherited Cancer Genome Testing Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Inherited Cancer Genome Testing Sales Sites and Area Served
Table 12. Manufacturers Inherited Cancer Genome Testing Product Type
Table 13. Global Inherited Cancer Genome Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Inherited Cancer Genome Testing
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Inherited Cancer Genome Testing Market Challenges
Table 22. Global Inherited Cancer Genome Testing Sales by Type (K Units)
Table 23. Global Inherited Cancer Genome Testing Market Size by Type (M USD)
Table 24. Global Inherited Cancer Genome Testing Sales (K Units) by Type (2019-2024)
Table 25. Global Inherited Cancer Genome Testing Sales Market Share by Type (2019-2024)
Table 26. Global Inherited Cancer Genome Testing Market Size (M USD) by Type (2019-2024)
Table 27. Global Inherited Cancer Genome Testing Market Size Share by Type (2019-2024)
Table 28. Global Inherited Cancer Genome Testing Price (USD/Unit) by Type (2019-2024)
Table 29. Global Inherited Cancer Genome Testing Sales (K Units) by Application
Table 30. Global Inherited Cancer Genome Testing Market Size by Application
Table 31. Global Inherited Cancer Genome Testing Sales by Application (2019-2024) & (K Units)
Table 32. Global Inherited Cancer Genome Testing Sales Market Share by Application (2019-2024)
Table 33. Global Inherited Cancer Genome Testing Sales by Application (2019-2024) & (M USD)
Table 34. Global Inherited Cancer Genome Testing Market Share by Application (2019-2024)
Table 35. Global Inherited Cancer Genome Testing Sales Growth Rate by Application (2019-2024)
Table 36. Global Inherited Cancer Genome Testing Sales by Region (2019-2024) & (K Units)
Table 37. Global Inherited Cancer Genome Testing Sales Market Share by Region (2019-2024)
Table 38. North America Inherited Cancer Genome Testing Sales by Country (2019-2024) & (K Units)
Table 39. Europe Inherited Cancer Genome Testing Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Inherited Cancer Genome Testing Sales by Region (2019-2024) & (K Units)
Table 41. South America Inherited Cancer Genome Testing Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Inherited Cancer Genome Testing Sales by Region (2019-2024) & (K Units)
Table 43. 23andMe Inherited Cancer Genome Testing Basic Information
Table 44. 23andMe Inherited Cancer Genome Testing Product Overview
Table 45. 23andMe Inherited Cancer Genome Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. 23andMe Business Overview
Table 47. 23andMe Inherited Cancer Genome Testing SWOT Analysis
Table 48. 23andMe Recent Developments
Table 49. Agilent Technologies Inherited Cancer Genome Testing Basic Information
Table 50. Agilent Technologies Inherited Cancer Genome Testing Product Overview
Table 51. Agilent Technologies Inherited Cancer Genome Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Agilent Technologies Business Overview
Table 53. Agilent Technologies Inherited Cancer Genome Testing SWOT Analysis
Table 54. Agilent Technologies Recent Developments
Table 55. Bio-Rad Laboratories Inherited Cancer Genome Testing Basic Information
Table 56. Bio-Rad Laboratories Inherited Cancer Genome Testing Product Overview
Table 57. Bio-Rad Laboratories Inherited Cancer Genome Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Bio-Rad Laboratories Inherited Cancer Genome Testing SWOT Analysis
Table 59. Bio-Rad Laboratories Business Overview
Table 60. Bio-Rad Laboratories Recent Developments
Table 61. Centogene Inherited Cancer Genome Testing Basic Information
Table 62. Centogene Inherited Cancer Genome Testing Product Overview
Table 63. Centogene Inherited Cancer Genome Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Centogene Business Overview
Table 65. Centogene Recent Developments
Table 66. Color Genomics Inherited Cancer Genome Testing Basic Information
Table 67. Color Genomics Inherited Cancer Genome Testing Product Overview
Table 68. Color Genomics Inherited Cancer Genome Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Color Genomics Business Overview
Table 70. Color Genomics Recent Developments
Table 71. Gene By Gene Inherited Cancer Genome Testing Basic Information
Table 72. Gene By Gene Inherited Cancer Genome Testing Product Overview
Table 73. Gene By Gene Inherited Cancer Genome Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Gene By Gene Business Overview
Table 75. Gene By Gene Recent Developments
Table 76. Illumina Inherited Cancer Genome Testing Basic Information
Table 77. Illumina Inherited Cancer Genome Testing Product Overview
Table 78. Illumina Inherited Cancer Genome Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Illumina Business Overview
Table 80. Illumina Recent Developments
Table 81. LabCorp Inherited Cancer Genome Testing Basic Information
Table 82. LabCorp Inherited Cancer Genome Testing Product Overview
Table 83. LabCorp Inherited Cancer Genome Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. LabCorp Business Overview
Table 85. LabCorp Recent Developments
Table 86. Myriad Genetics Inherited Cancer Genome Testing Basic Information
Table 87. Myriad Genetics Inherited Cancer Genome Testing Product Overview
Table 88. Myriad Genetics Inherited Cancer Genome Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Myriad Genetics Business Overview
Table 90. Myriad Genetics Recent Developments
Table 91. Positive Bioscience Inherited Cancer Genome Testing Basic Information
Table 92. Positive Bioscience Inherited Cancer Genome Testing Product Overview
Table 93. Positive Bioscience Inherited Cancer Genome Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Positive Bioscience Business Overview
Table 95. Positive Bioscience Recent Developments
Table 96. Quest Diagnostics Inherited Cancer Genome Testing Basic Information
Table 97. Quest Diagnostics Inherited Cancer Genome Testing Product Overview
Table 98. Quest Diagnostics Inherited Cancer Genome Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Quest Diagnostics Business Overview
Table 100. Quest Diagnostics Recent Developments
Table 101. Thermo Fisher Scientific Inherited Cancer Genome Testing Basic Information
Table 102. Thermo Fisher Scientific Inherited Cancer Genome Testing Product Overview
Table 103. Thermo Fisher Scientific Inherited Cancer Genome Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Thermo Fisher Scientific Business Overview
Table 105. Thermo Fisher Scientific Recent Developments
Table 106. Global Inherited Cancer Genome Testing Sales Forecast by Region (2025-2030) & (K Units)
Table 107. Global Inherited Cancer Genome Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 108. North America Inherited Cancer Genome Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 109. North America Inherited Cancer Genome Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 110. Europe Inherited Cancer Genome Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 111. Europe Inherited Cancer Genome Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 112. Asia Pacific Inherited Cancer Genome Testing Sales Forecast by Region (2025-2030) & (K Units)
Table 113. Asia Pacific Inherited Cancer Genome Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 114. South America Inherited Cancer Genome Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 115. South America Inherited Cancer Genome Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 116. Middle East and Africa Inherited Cancer Genome Testing Consumption Forecast by Country (2025-2030) & (Units)
Table 117. Middle East and Africa Inherited Cancer Genome Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 118. Global Inherited Cancer Genome Testing Sales Forecast by Type (2025-2030) & (K Units)
Table 119. Global Inherited Cancer Genome Testing Market Size Forecast by Type (2025-2030) & (M USD)
Table 120. Global Inherited Cancer Genome Testing Price Forecast by Type (2025-2030) & (USD/Unit)
Table 121. Global Inherited Cancer Genome Testing Sales (K Units) Forecast by Application (2025-2030)
Table 122. Global Inherited Cancer Genome Testing Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Inherited Cancer Genome Testing Market Size Comparison by Region (M USD)
Table 5. Global Inherited Cancer Genome Testing Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Inherited Cancer Genome Testing Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Inherited Cancer Genome Testing Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Inherited Cancer Genome Testing Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inherited Cancer Genome Testing as of 2022)
Table 10. Global Market Inherited Cancer Genome Testing Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Inherited Cancer Genome Testing Sales Sites and Area Served
Table 12. Manufacturers Inherited Cancer Genome Testing Product Type
Table 13. Global Inherited Cancer Genome Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Inherited Cancer Genome Testing
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Inherited Cancer Genome Testing Market Challenges
Table 22. Global Inherited Cancer Genome Testing Sales by Type (K Units)
Table 23. Global Inherited Cancer Genome Testing Market Size by Type (M USD)
Table 24. Global Inherited Cancer Genome Testing Sales (K Units) by Type (2019-2024)
Table 25. Global Inherited Cancer Genome Testing Sales Market Share by Type (2019-2024)
Table 26. Global Inherited Cancer Genome Testing Market Size (M USD) by Type (2019-2024)
Table 27. Global Inherited Cancer Genome Testing Market Size Share by Type (2019-2024)
Table 28. Global Inherited Cancer Genome Testing Price (USD/Unit) by Type (2019-2024)
Table 29. Global Inherited Cancer Genome Testing Sales (K Units) by Application
Table 30. Global Inherited Cancer Genome Testing Market Size by Application
Table 31. Global Inherited Cancer Genome Testing Sales by Application (2019-2024) & (K Units)
Table 32. Global Inherited Cancer Genome Testing Sales Market Share by Application (2019-2024)
Table 33. Global Inherited Cancer Genome Testing Sales by Application (2019-2024) & (M USD)
Table 34. Global Inherited Cancer Genome Testing Market Share by Application (2019-2024)
Table 35. Global Inherited Cancer Genome Testing Sales Growth Rate by Application (2019-2024)
Table 36. Global Inherited Cancer Genome Testing Sales by Region (2019-2024) & (K Units)
Table 37. Global Inherited Cancer Genome Testing Sales Market Share by Region (2019-2024)
Table 38. North America Inherited Cancer Genome Testing Sales by Country (2019-2024) & (K Units)
Table 39. Europe Inherited Cancer Genome Testing Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Inherited Cancer Genome Testing Sales by Region (2019-2024) & (K Units)
Table 41. South America Inherited Cancer Genome Testing Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Inherited Cancer Genome Testing Sales by Region (2019-2024) & (K Units)
Table 43. 23andMe Inherited Cancer Genome Testing Basic Information
Table 44. 23andMe Inherited Cancer Genome Testing Product Overview
Table 45. 23andMe Inherited Cancer Genome Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. 23andMe Business Overview
Table 47. 23andMe Inherited Cancer Genome Testing SWOT Analysis
Table 48. 23andMe Recent Developments
Table 49. Agilent Technologies Inherited Cancer Genome Testing Basic Information
Table 50. Agilent Technologies Inherited Cancer Genome Testing Product Overview
Table 51. Agilent Technologies Inherited Cancer Genome Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Agilent Technologies Business Overview
Table 53. Agilent Technologies Inherited Cancer Genome Testing SWOT Analysis
Table 54. Agilent Technologies Recent Developments
Table 55. Bio-Rad Laboratories Inherited Cancer Genome Testing Basic Information
Table 56. Bio-Rad Laboratories Inherited Cancer Genome Testing Product Overview
Table 57. Bio-Rad Laboratories Inherited Cancer Genome Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Bio-Rad Laboratories Inherited Cancer Genome Testing SWOT Analysis
Table 59. Bio-Rad Laboratories Business Overview
Table 60. Bio-Rad Laboratories Recent Developments
Table 61. Centogene Inherited Cancer Genome Testing Basic Information
Table 62. Centogene Inherited Cancer Genome Testing Product Overview
Table 63. Centogene Inherited Cancer Genome Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Centogene Business Overview
Table 65. Centogene Recent Developments
Table 66. Color Genomics Inherited Cancer Genome Testing Basic Information
Table 67. Color Genomics Inherited Cancer Genome Testing Product Overview
Table 68. Color Genomics Inherited Cancer Genome Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Color Genomics Business Overview
Table 70. Color Genomics Recent Developments
Table 71. Gene By Gene Inherited Cancer Genome Testing Basic Information
Table 72. Gene By Gene Inherited Cancer Genome Testing Product Overview
Table 73. Gene By Gene Inherited Cancer Genome Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Gene By Gene Business Overview
Table 75. Gene By Gene Recent Developments
Table 76. Illumina Inherited Cancer Genome Testing Basic Information
Table 77. Illumina Inherited Cancer Genome Testing Product Overview
Table 78. Illumina Inherited Cancer Genome Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Illumina Business Overview
Table 80. Illumina Recent Developments
Table 81. LabCorp Inherited Cancer Genome Testing Basic Information
Table 82. LabCorp Inherited Cancer Genome Testing Product Overview
Table 83. LabCorp Inherited Cancer Genome Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. LabCorp Business Overview
Table 85. LabCorp Recent Developments
Table 86. Myriad Genetics Inherited Cancer Genome Testing Basic Information
Table 87. Myriad Genetics Inherited Cancer Genome Testing Product Overview
Table 88. Myriad Genetics Inherited Cancer Genome Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Myriad Genetics Business Overview
Table 90. Myriad Genetics Recent Developments
Table 91. Positive Bioscience Inherited Cancer Genome Testing Basic Information
Table 92. Positive Bioscience Inherited Cancer Genome Testing Product Overview
Table 93. Positive Bioscience Inherited Cancer Genome Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Positive Bioscience Business Overview
Table 95. Positive Bioscience Recent Developments
Table 96. Quest Diagnostics Inherited Cancer Genome Testing Basic Information
Table 97. Quest Diagnostics Inherited Cancer Genome Testing Product Overview
Table 98. Quest Diagnostics Inherited Cancer Genome Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Quest Diagnostics Business Overview
Table 100. Quest Diagnostics Recent Developments
Table 101. Thermo Fisher Scientific Inherited Cancer Genome Testing Basic Information
Table 102. Thermo Fisher Scientific Inherited Cancer Genome Testing Product Overview
Table 103. Thermo Fisher Scientific Inherited Cancer Genome Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Thermo Fisher Scientific Business Overview
Table 105. Thermo Fisher Scientific Recent Developments
Table 106. Global Inherited Cancer Genome Testing Sales Forecast by Region (2025-2030) & (K Units)
Table 107. Global Inherited Cancer Genome Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 108. North America Inherited Cancer Genome Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 109. North America Inherited Cancer Genome Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 110. Europe Inherited Cancer Genome Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 111. Europe Inherited Cancer Genome Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 112. Asia Pacific Inherited Cancer Genome Testing Sales Forecast by Region (2025-2030) & (K Units)
Table 113. Asia Pacific Inherited Cancer Genome Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 114. South America Inherited Cancer Genome Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 115. South America Inherited Cancer Genome Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 116. Middle East and Africa Inherited Cancer Genome Testing Consumption Forecast by Country (2025-2030) & (Units)
Table 117. Middle East and Africa Inherited Cancer Genome Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 118. Global Inherited Cancer Genome Testing Sales Forecast by Type (2025-2030) & (K Units)
Table 119. Global Inherited Cancer Genome Testing Market Size Forecast by Type (2025-2030) & (M USD)
Table 120. Global Inherited Cancer Genome Testing Price Forecast by Type (2025-2030) & (USD/Unit)
Table 121. Global Inherited Cancer Genome Testing Sales (K Units) Forecast by Application (2025-2030)
Table 122. Global Inherited Cancer Genome Testing Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Inherited Cancer Genome Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Inherited Cancer Genome Testing Market Size (M USD), 2019-2030
Figure 5. Global Inherited Cancer Genome Testing Market Size (M USD) (2019-2030)
Figure 6. Global Inherited Cancer Genome Testing Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Inherited Cancer Genome Testing Market Size by Country (M USD)
Figure 11. Inherited Cancer Genome Testing Sales Share by Manufacturers in 2023
Figure 12. Global Inherited Cancer Genome Testing Revenue Share by Manufacturers in 2023
Figure 13. Inherited Cancer Genome Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Inherited Cancer Genome Testing Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Inherited Cancer Genome Testing Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Inherited Cancer Genome Testing Market Share by Type
Figure 18. Sales Market Share of Inherited Cancer Genome Testing by Type (2019-2024)
Figure 19. Sales Market Share of Inherited Cancer Genome Testing by Type in 2023
Figure 20. Market Size Share of Inherited Cancer Genome Testing by Type (2019-2024)
Figure 21. Market Size Market Share of Inherited Cancer Genome Testing by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Inherited Cancer Genome Testing Market Share by Application
Figure 24. Global Inherited Cancer Genome Testing Sales Market Share by Application (2019-2024)
Figure 25. Global Inherited Cancer Genome Testing Sales Market Share by Application in 2023
Figure 26. Global Inherited Cancer Genome Testing Market Share by Application (2019-2024)
Figure 27. Global Inherited Cancer Genome Testing Market Share by Application in 2023
Figure 28. Global Inherited Cancer Genome Testing Sales Growth Rate by Application (2019-2024)
Figure 29. Global Inherited Cancer Genome Testing Sales Market Share by Region (2019-2024)
Figure 30. North America Inherited Cancer Genome Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Inherited Cancer Genome Testing Sales Market Share by Country in 2023
Figure 32. U.S. Inherited Cancer Genome Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Inherited Cancer Genome Testing Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Inherited Cancer Genome Testing Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Inherited Cancer Genome Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Inherited Cancer Genome Testing Sales Market Share by Country in 2023
Figure 37. Germany Inherited Cancer Genome Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Inherited Cancer Genome Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Inherited Cancer Genome Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Inherited Cancer Genome Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Inherited Cancer Genome Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Inherited Cancer Genome Testing Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Inherited Cancer Genome Testing Sales Market Share by Region in 2023
Figure 44. China Inherited Cancer Genome Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Inherited Cancer Genome Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Inherited Cancer Genome Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Inherited Cancer Genome Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Inherited Cancer Genome Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Inherited Cancer Genome Testing Sales and Growth Rate (K Units)
Figure 50. South America Inherited Cancer Genome Testing Sales Market Share by Country in 2023
Figure 51. Brazil Inherited Cancer Genome Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Inherited Cancer Genome Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Inherited Cancer Genome Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Inherited Cancer Genome Testing Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Inherited Cancer Genome Testing Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Inherited Cancer Genome Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Inherited Cancer Genome Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Inherited Cancer Genome Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Inherited Cancer Genome Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Inherited Cancer Genome Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Inherited Cancer Genome Testing Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Inherited Cancer Genome Testing Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Inherited Cancer Genome Testing Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Inherited Cancer Genome Testing Market Share Forecast by Type (2025-2030)
Figure 65. Global Inherited Cancer Genome Testing Sales Forecast by Application (2025-2030)
Figure 66. Global Inherited Cancer Genome Testing Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Inherited Cancer Genome Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Inherited Cancer Genome Testing Market Size (M USD), 2019-2030
Figure 5. Global Inherited Cancer Genome Testing Market Size (M USD) (2019-2030)
Figure 6. Global Inherited Cancer Genome Testing Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Inherited Cancer Genome Testing Market Size by Country (M USD)
Figure 11. Inherited Cancer Genome Testing Sales Share by Manufacturers in 2023
Figure 12. Global Inherited Cancer Genome Testing Revenue Share by Manufacturers in 2023
Figure 13. Inherited Cancer Genome Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Inherited Cancer Genome Testing Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Inherited Cancer Genome Testing Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Inherited Cancer Genome Testing Market Share by Type
Figure 18. Sales Market Share of Inherited Cancer Genome Testing by Type (2019-2024)
Figure 19. Sales Market Share of Inherited Cancer Genome Testing by Type in 2023
Figure 20. Market Size Share of Inherited Cancer Genome Testing by Type (2019-2024)
Figure 21. Market Size Market Share of Inherited Cancer Genome Testing by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Inherited Cancer Genome Testing Market Share by Application
Figure 24. Global Inherited Cancer Genome Testing Sales Market Share by Application (2019-2024)
Figure 25. Global Inherited Cancer Genome Testing Sales Market Share by Application in 2023
Figure 26. Global Inherited Cancer Genome Testing Market Share by Application (2019-2024)
Figure 27. Global Inherited Cancer Genome Testing Market Share by Application in 2023
Figure 28. Global Inherited Cancer Genome Testing Sales Growth Rate by Application (2019-2024)
Figure 29. Global Inherited Cancer Genome Testing Sales Market Share by Region (2019-2024)
Figure 30. North America Inherited Cancer Genome Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Inherited Cancer Genome Testing Sales Market Share by Country in 2023
Figure 32. U.S. Inherited Cancer Genome Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Inherited Cancer Genome Testing Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Inherited Cancer Genome Testing Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Inherited Cancer Genome Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Inherited Cancer Genome Testing Sales Market Share by Country in 2023
Figure 37. Germany Inherited Cancer Genome Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Inherited Cancer Genome Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Inherited Cancer Genome Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Inherited Cancer Genome Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Inherited Cancer Genome Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Inherited Cancer Genome Testing Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Inherited Cancer Genome Testing Sales Market Share by Region in 2023
Figure 44. China Inherited Cancer Genome Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Inherited Cancer Genome Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Inherited Cancer Genome Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Inherited Cancer Genome Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Inherited Cancer Genome Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Inherited Cancer Genome Testing Sales and Growth Rate (K Units)
Figure 50. South America Inherited Cancer Genome Testing Sales Market Share by Country in 2023
Figure 51. Brazil Inherited Cancer Genome Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Inherited Cancer Genome Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Inherited Cancer Genome Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Inherited Cancer Genome Testing Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Inherited Cancer Genome Testing Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Inherited Cancer Genome Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Inherited Cancer Genome Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Inherited Cancer Genome Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Inherited Cancer Genome Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Inherited Cancer Genome Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Inherited Cancer Genome Testing Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Inherited Cancer Genome Testing Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Inherited Cancer Genome Testing Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Inherited Cancer Genome Testing Market Share Forecast by Type (2025-2030)
Figure 65. Global Inherited Cancer Genome Testing Sales Forecast by Application (2025-2030)
Figure 66. Global Inherited Cancer Genome Testing Market Share Forecast by Application (2025-2030)
